Showing results (321-330 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|December 19, 2025
Predicting rTMS treatment response in schizophrenia using interpretable machine learning: a SHAP-based analysisJingyuan LinTherapeutic Advances in Psychopharmacology|December 15, 2025
From model psychosis to rapid antidepressant: a historical and conceptual review of ketamine's psychiatric historyCasimiro Cabrera Abreu, Aleksandar Biorac, Ross J Baldessarini, et al.Therapeutic Advances in Psychopharmacology|April 29, 2025
Investigation on the factors associated with maintenance of paliperidone long-acting injection in the real-world treatment of patients with schizophreniaNuree Kang, Ae Jeong Jo, Sung Woo Joo, et al.Therapeutic Advances in Psychopharmacology|April 7, 2025
Relationship between resilience and mental health among COVID-19 bereaved people: the mediating role of dual process copingLiping Wu, Siying Chen, Suqin TangTherapeutic Advances in Psychopharmacology|November 17, 2025
Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysisAhmed Elmosalamy, Idil Tarikogullari, Liliana Patarroyo-Rodriguez, et al.Therapeutic Advances in Psychopharmacology|November 7, 2025
Psychotropic medications adherence status and its determinants among older adults with severe affective and psychotic disorders: a multicenter cross-sectional studyWoretaw Sisay Zewdu, Tigabu Eskeziya Zerihun, Desalegn Addis Mussie, et al.Therapeutic Advances in Psychopharmacology|September 11, 2025
Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysisStanley Wong, Gray Meckling, Nicholas Fabiano, et al.Therapeutic Advances in Psychopharmacology|July 25, 2014
Ivabradine, a novel treatment for clozapine-induced sinus tachycardia: a case seriesJohn Lally, Jennifer Brook, Thomas Dixon, et al.Therapeutic Advances in Psychopharmacology|December 3, 2013
A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in agitated elderly patients with schizophreniaHidenobu Suzuki, Keishi Gen, Yuki TakahashiTherapeutic Advances in Psychopharmacology|December 3, 2013
Prolonged hypothermia due to olanzapine in the setting of renal failure: a case report and review of the literatureAnkit Kansagra, Sanket Patel, Susan Renee WilcoxPageof 55